Literature DB >> 16078250

Chlamydia/gonorrhea combo and HR HPV DNA testing in liquid-based pap.

Clementine M Hawthorne1, Phillip J Farber, Marluce Bibbo.   

Abstract

Residual material from liquid-based pap (LBP) test has been used for molecular testing of Human Papilloma Virus (HR HPV) DNA. LBP test specimens (1,025) were evaluated to determine how often residual material was insufficient to perform microbiological testing. The specimens were tested for Chlamydia trachomatis and Neisseria gonorrhea (CCGT) alone and in combination with HR HPV(CCGT + HR HPV), using PCR method and HYBRID CAPTURE 2, respectively. A minimum volume of 5 ml (CCGT: 0.5-1 ml, HPV: 4 ml) of residual material is required for both the tests. The residual material was measured at >5 ml, < or =5 ml, and 0.5 ml volumes and documented. Results were tabulated. The insufficient rate for cases submitted for CCGT was 0.2% and 7.6% for HR HPV, with a detection rate of 40.9% for HR HPV. Utilizing residual material from LBP test for microbiological testing, as well as DNA testing for HR HPV is a convenient, cost-effective means to enhance patient care. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16078250     DOI: 10.1002/dc.20325

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  3 in total

1.  APTIMA assay on SurePath liquid-based cervical samples compared to endocervical swab samples facilitated by a real time database.

Authors:  Samer N Khader; Kathie Schlesinger; Josh Grossman; Richard I Henry; Mark Suhrland; Amy S Fox
Journal:  Cytojournal       Date:  2010-07-02       Impact factor: 2.091

2.  Abilities of APTIMA, AMPLICOR, and ProbeTec assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in PreservCyt ThinPrep Liquid-based Pap samples.

Authors:  M Chernesky; D Jang; E Portillo; S Chong; M Smieja; K Luinstra; A Petrich; C Macritchie; R Ewert; B Hayhoe; A Sarabia; F Thompson
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

3.  Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays.

Authors:  Max Chernesky; Gregory G Freund; Edward Hook; Peter Leone; Peter D'Ascoli; Mark Martens
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.